To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TSC2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
614 supporting clones for gene TSC2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_57199266   .a 1 to 700 28 to 729   tiling clone,   702/729
(96 %)
12 diff
(98.4 %id)
BI821575 pooled brain, lung, testis .a 6 to 700 1 to 697   tiling clone,   697/697
(100 %)
9 diff
(98.8 %id)
DC402106 testis .a 434 to 998 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
DC399920 testis .a 526 to 925 1 to 400   tiling clone,   400/400
(100 %)
0 diff
(100 %id)
NM_000548.3   .a 530 to 6160 1 to 5631   RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 5631/5631
(100 %)
0 diff
(100 %id)
X75621 brain .a 618 to 6160 1 to 5543   tiling clone,   5543/5543
(100 %)
2 diff
(100.0 %id)
BE876254 large cell carcinoma, undifferentiated, lung .a 4163 to 4859 1 to 694       694/703
(98 %)
5 diff
(99.3 %id)
DA090182 cerebellum .a 4312 to 4875 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BG898698 cartilage .a 4334 to 4871 50 to 587       538/587
(91 %)
6 diff
(99.0 %id)
DA316794 hippocampus .b 1 to 531 2 to 533   tiling clone, capped   532/532
(100 %)
3 diff
(99.5 %id)
NM_001114382.1   .b 9 to 5570 1 to 5562 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 5562/5562
(100 %)
0 diff
(100 %id)
DR003550 hippocampus .b 14 to 625 9 to 621       613/621
(98 %)
10 diff
(98.4 %id)
DA123447 cerebellum .b 29 to 555 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA195525 amygdala .b 29 to 580 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA290017 hippocampus .b 29 to 607 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA315456 hippocampus .b 29 to 553 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DB061952 testis .b 33 to 588 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
DA056546 cerebellum .b 35 to 634 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
DA107914 cerebellum .b 35 to 595 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA126464 cerebellum .b 35 to 607 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA239009 brain .b 35 to 635 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DA460307 tongue, tumor tissue .b 35 to 601 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA808190 brain .b 35 to 599 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB064559 testis .b 35 to 605 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB067136 testis .b 35 to 563 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB075096 testis .b 35 to 584 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB080341 testis .b 35 to 601 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB087377 testis .b 35 to 599 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB097421 testis .b 35 to 601 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB135159 thymus .b 35 to 581 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB213317 trachea .b 35 to 580 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB233411 trachea .b 35 to 609 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB266997 uterus .b 35 to 624 2 to 591   capped   590/595
(99 %)
2 diff
(99.7 %id)
AU100174   .b 36 to 335 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
AU107585   .b 36 to 85 1 to 50       50/50
(100 %)
0 diff
(100 %id)
DB291957 uterus .b 37 to 619 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DC333174 hippocampus .b 38 to 443 1 to 406       406/406
(100 %)
3 diff
(99.3 %id)
BC150300 Clones donated by RIKEN .b 40 to 5570 1 to 5531 A210V K704E L1015M I1649M tiling clone, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 5531/5531
(100 %)
4 diff
(100.0 %id)
DA112099 cerebellum .b 40 to 589 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB501174 hypothalamus .b 41 to 765 1 to 724       724/727
(99 %)
17 diff
(97.7 %id)
DA110791 cerebellum .b 43 to 589 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA314206 hippocampus .b 43 to 606 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA186269 amygdala .b 45 to 599 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA247308 brain .b 45 to 625 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA783169 brain .b 45 to 611 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
CN373205 embryonic stem cells, cell lines H1, H7, andH9 .b 53 to 679 1 to 626       626/626
(100 %)
4 diff
(99.4 %id)
CN373197 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 54 to 582 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
DR001527 fetal brain .b 100 to 864 1 to 765       765/765
(100 %)
6 diff
(99.3 %id)
AI565319 Kidney .b 120 to 323 205 to 1       205/206
(99 %)
3 diff
(98.6 %id)
BG413371 Kidney .b 123 to 323 201 to 1       201/201
(100 %)
0 diff
(100 %id)
BF002708 colon, colon tumor, RER+ .b 145 to 387 243 to 1       243/243
(100 %)
9 diff
(96.3 %id)
DA325783 hippocampus .b 164 to 726 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BF000407 colon, colon tumor, RER+ .b 167 to 354 190 to 3       188/190
(98 %)
0 diff
(100 %id)
AL700802 human skeletal muscle .b 318 to 544 1 to 227       227/227
(100 %)
2 diff
(99.2 %id)
BU528372 epidermoid carcinoma, cell line, lung .b 348 to 1246 34 to 931   tiling clone,   900/931
(96 %)
17 diff
(98.2 %id)
BQ959164 epidermoid carcinoma, cell line, lung .b 353 to 1233 26 to 914       889/926
(96 %)
26 diff
(97.2 %id)
BE644999 pooled .b 390 to 1083 1 to 694     Submitted on the opposite strand 694/694
(100 %)
1 diff
(99.9 %id)
BF194994 fibrotheoma, ovary .b 408 to 943 1 to 536     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
AA706735 parathyroid gland, parathyroid tumor .b 414 to 948 1 to 530     Submitted on the opposite strand 530/530
(100 %)
4 diff
(99.3 %id)
AI349469 lung .b 414 to 552 1 to 139     Submitted on the opposite strand 139/139
(100 %)
1 diff
(99.3 %id)
AI457675 pooled .b 414 to 882 1 to 469     Submitted on the opposite strand 469/469
(100 %)
13 diff
(97.3 %id)
AW051638 pooled .b 414 to 999 1 to 586     Submitted on the opposite strand 586/586
(100 %)
3 diff
(99.5 %id)
AA730243 germinal center B cell .b 453 to 561 1 to 109     Submitted on the opposite strand 109/109
(100 %)
5 diff
(95.5 %id)
AA764748 germinal center B cell .b 469 to 744 1 to 275     Submitted on the opposite strand 275/275
(100 %)
1 diff
(99.7 %id)
H37774 eye, retina .b 488 to 795 1 to 309     Submitted on the opposite strand 309/360
(85 %)
6 diff
(98.4 %id)
AA864519 pooled germ cell tumors .b 488 to 819 1 to 332     Submitted on the opposite strand 332/332
(100 %)
5 diff
(98.5 %id)
DB097317 testis .b 496 to 1080 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CA392462 eye, RPE/choroid .b 506 to 1141 1 to 636       636/636
(100 %)
0 diff
(100 %id)
CN373201 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 551 to 952 1 to 402       402/402
(100 %)
1 diff
(99.8 %id)
BU430460 lymph .b 680 to 1166 8 to 494       487/494
(98 %)
14 diff
(97.2 %id)
TI_154151901   .b 680 to 1354 80 to 753       674/680
(99 %)
28 diff
(95.9 %id)
BQ054623 lymph, lymphoma, cell line .b 761 to 1681 1 to 925       925/958
(96 %)
17 diff
(98.3 %id)
BQ054644 lymph, lymphoma, cell line .b 761 to 1656 1 to 904       902/1029
(87 %)
26 diff
(97.5 %id)
BQ062032 lymph, lymphoma, cell line .b 761 to 1712 1 to 954       954/1008
(94 %)
16 diff
(98.5 %id)
BQ063787 lymph, lymphoma, cell line .b 761 to 1712 1 to 964       964/1034
(93 %)
19 diff
(98.2 %id)
BQ066412 lymph, lymphoma, cell line .b 761 to 1704 1 to 948       948/977
(97 %)
25 diff
(97.5 %id)
CF138897 lymph .b 807 to 1302 7 to 502       496/502
(98 %)
2 diff
(99.7 %id)
TI_154169032   .b 807 to 1322 77 to 592       516/516
(100 %)
2 diff
(99.7 %id)
DB086018 testis .b 822 to 1380 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB223712 trachea .b 1160 to 1718 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CN373204 embryonic stem cells, cell lines H1, H7, andH9 .b 1172 to 1882 1 to 711       711/711
(100 %)
2 diff
(99.8 %id)
DB070464 testis .b 1231 to 1768 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA113542 cerebellum .b 1278 to 1821 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB068145 testis .b 1278 to 1825 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
CF593993 Human Placenta, placenta .b 1288 to 1803 28 to 546       519/1127
(46 %)
9 diff
(99.3 %id)
CK000328 mixed .b 1317 to 2090 8 to 781       774/785
(98 %)
8 diff
(99.0 %id)
BG989509 head_neck .b 1326 to 1545 1 to 220       220/220
(100 %)
3 diff
(98.7 %id)
DA499582 brain .b 1332 to 1825 2 to 495   capped   494/494
(100 %)
1 diff
(99.8 %id)
BI060123 uterus_tumor .b 1373 to 1601 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
CF135856 lymph .b 1413 to 1595 1 to 183       183/183
(100 %)
5 diff
(97.3 %id)
CN373194 embryonic stem cells, cell lines H1, H7, andH9 .b 1445 to 2139 1 to 695       695/695
(100 %)
3 diff
(99.6 %id)
AW732333 Kidney, renal cell adenocarcinoma .b 1493 to 2038 1 to 545       545/545
(100 %)
5 diff
(99.1 %id)
DA231122 brain .b 1506 to 2057 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BI023340 marrow .b 1511 to 1918 412 to 5       408/412
(99 %)
1 diff
(99.8 %id)
DA233205 brain .b 1537 to 2124 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA494075 brain .b 1548 to 2117 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB123324 thymus .b 1569 to 2035 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DA188271 amygdala .b 1644 to 2171 2 to 529   capped   528/529
(99 %)
1 diff
(99.9 %id)
DA224441 brain .b 1661 to 2210 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
AW651733 cervical carcinoma cell line, cervix .b 1708 to 2271 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
CN373199 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1720 to 2297 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CU442919 epidermis .b 1772 to 2559 4 to 791       788/791
(99 %)
7 diff
(99.2 %id)
AW504341 lymph .b 1784 to 2178 8 to 402     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 395/402
(98 %)
10 diff
(97.6 %id)
TI_154160484   .b 1784 to 2321 86 to 621       536/539
(99 %)
14 diff
(97.5 %id)
DA126487 cerebellum .b 1864 to 2431 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB063219 testis .b 1878 to 2427 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA946966 Spleen .b 1879 to 2433 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BE867471 adenocarcinoma, colon .b 1918 to 2626 1 to 705       705/874
(80 %)
9 diff
(99.0 %id)
DA183787 amygdala .b 1990 to 2553 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BE784295 eye, retinoblastoma .b 1996 to 2676 29 to 708       680/895
(75 %)
37 diff
(95.9 %id)
BE779535 eye, retinoblastoma .b 2101 to 2667 1 to 566       566/880
(64 %)
30 diff
(96.6 %id)
CA396375 eye, RPE/choroid .b 2137 to 2534 1 to 398       398/398
(100 %)
0 diff
(100 %id)
TI_44384863   .b 2137 to 2908 90 to 859   tiling clone,   770/770
(100 %)
4 diff
(99.5 %id)
BI554180 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2139 to 2908 1 to 768       768/768
(100 %)
4 diff
(99.5 %id)
DB288276 uterus .b 2181 to 2736 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB043462 testis .b 2200 to 2764 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BF852963 lung_normal .b 2254 to 2656 1 to 404       404/404
(100 %)
5 diff
(98.8 %id)
DB160509 thymus .b 2271 to 2846 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DB138322 thymus .b 2272 to 2807 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA865071 placenta .b 2273 to 2855 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB149335 thymus .b 2276 to 2832 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BG002471 placenta_normal .b 2282 to 2755 515 to 43       473/515
(91 %)
5 diff
(99.1 %id)
DB076414 testis .b 2285 to 2862 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB134461 thymus .b 2324 to 2830 2 to 506   capped   505/505
(100 %)
4 diff
(99.3 %id)
BU191484 ductal carcinoma, cell line, Pancreas .b 2340 to 3169 17 to 855       842/1028
(81 %)
25 diff
(97.6 %id)
BQ719672 sympathetic trunk .b 2351 to 2753 12 to 416       405/1146
(35 %)
12 diff
(99.0 %id)
BF842046 head_neck .b 2356 to 2733 383 to 4     Submitted on the opposite strand 380/383
(99 %)
1 diff
(99.8 %id)
CD675300 eye, lens .b 2365 to 3028 1 to 664       664/664
(100 %)
0 diff
(100 %id)
DA901427   .b 2435 to 2942 2 to 512   capped   511/511
(100 %)
3 diff
(99.5 %id)
DA526238 brain .b 2437 to 2992 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA805904 brain .b 2600 to 3080 2 to 482   capped   481/483
(99 %)
2 diff
(99.6 %id)
AW391886 stomach .b 2729 to 2960 1 to 233       233/233
(100 %)
1 diff
(99.6 %id)
AI142773 pooled .b 2783 to 2920 138 to 1       138/142
(97 %)
12 diff
(91.6 %id)
DA521395 brain .b 2952 to 3524 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA486283 brain .b 2953 to 3454 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
DA495209 brain .b 3058 to 3628 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA781965 brain .b 3059 to 3627 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA436977 tongue, tumor tissue .b 3080 to 3660 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA738067   .b 3081 to 3752 2 to 673   capped   672/672
(100 %)
2 diff
(99.8 %id)
DB157181 thymus .b 3088 to 3666 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB157206 thymus .b 3088 to 3667 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA442751 tongue, tumor tissue .b 3090 to 3666 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA985767 synovial membrane tissue from rheumatioidarthritis .b 3093 to 3658 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BG255001 adenocarcinoma, cell line, Prostate .b 3094 to 3509 1 to 416       416/416
(100 %)
2 diff
(99.6 %id)
DA625488 Kidney .b 3104 to 3637 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA742967   .b 3110 to 3624 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
DA788957 brain .b 3113 to 3697 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BE560083 Burkitt lymphoma, lymph .b 3126 to 3373 39 to 287       249/287
(86 %)
8 diff
(97.3 %id)
BE561796 Burkitt lymphoma, lymph .b 3126 to 3923 43 to 841   available from MGC,   797/851
(93 %)
61 diff
(92.9 %id)
BE561918 Burkitt lymphoma, lymph .b 3126 to 3909 35 to 861   available from MGC,   646/866
(74 %)
42 diff
(95.2 %id)
BC046929 Lymph, Burkitt lymphoma .b 3127 to 5551 1 to 2425   available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 2425/2425
(100 %)
1 diff
(100.0 %id)
BC025364 Lymph, Burkitt lymphoma .b 3127 to 5551 1 to 2425   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 2425/2425
(100 %)
1 diff
(100.0 %id)
BI227230 Burkitt lymphoma, lymph .b 3127 to 3846 21 to 738       718/739
(97 %)
8 diff
(99.0 %id)
BI227377 Burkitt lymphoma, lymph .b 3127 to 3889 56 to 813       758/837
(90 %)
9 diff
(99.0 %id)
BE561642 Burkitt lymphoma, lymph .b 3128 to 3841 41 to 779       595/779
(76 %)
46 diff
(94.1 %id)
BI227305 Burkitt lymphoma, lymph .b 3128 to 3795 31 to 699       669/699
(95 %)
7 diff
(99.0 %id)
BI224744 Burkitt lymphoma, lymph .b 3130 to 3928 1 to 806       806/1015
(79 %)
28 diff
(97.3 %id)
BE562089 Burkitt lymphoma, lymph .b 3131 to 3923 41 to 857       813/940
(86 %)
61 diff
(93.6 %id)
AW732702 Burkitt lymphoma, lymph .b 3132 to 3687 1 to 558     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 558/558
(100 %)
1 diff
(99.9 %id)
BM467508 duodenal adenocarcinoma, cell line, small intestine .b 3140 to 3927 1 to 787       787/1131
(69 %)
4 diff
(99.7 %id)
BI225911 Burkitt lymphoma, lymph .b 3145 to 3756 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
BI226031 Burkitt lymphoma, lymph .b 3145 to 3953 1 to 812       812/812
(100 %)
14 diff
(98.3 %id)
BI226689 Burkitt lymphoma, lymph .b 3145 to 3954 1 to 806       806/807
(99 %)
9 diff
(98.9 %id)
BI227146 Burkitt lymphoma, lymph .b 3145 to 3928 1 to 790       790/818
(96 %)
30 diff
(96.4 %id)
BM051831 Burkitt lymphoma, lymph .b 3145 to 3822 1 to 677       677/677
(100 %)
1 diff
(99.9 %id)
BM051603 Burkitt lymphoma, lymph .b 3146 to 3928 1 to 781       781/804
(97 %)
11 diff
(98.7 %id)
BI224777 Burkitt lymphoma, lymph .b 3148 to 3927 1 to 786       786/849
(92 %)
15 diff
(98.3 %id)
AU124993   .b 3150 to 3818 2 to 669   capped   668/673
(99 %)
4 diff
(99.5 %id)
AW732659 Burkitt lymphoma, lymph .b 3159 to 3720 1 to 562     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 562/562
(100 %)
50 diff
(91.2 %id)
CX865213 embryonic stem .b 3167 to 3980 1 to 813       813/813
(100 %)
7 diff
(99.2 %id)
DA648942   .b 3213 to 3763 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA500666 brain .b 3215 to 3782 2 to 569   capped   568/570
(99 %)
2 diff
(99.7 %id)
DA935995 Spleen .b 3215 to 3772 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA110737 cerebellum .b 3216 to 3805 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA011258 adrenal gland .b 3217 to 3766 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA186229 amygdala .b 3217 to 3749 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA286321 corpus callosum .b 3218 to 3550 2 to 334   capped   333/333
(100 %)
0 diff
(100 %id)
DA156632 amygdala .b 3219 to 3750 2 to 536   capped   535/535
(100 %)
5 diff
(99.1 %id)
DA104523 cerebellum .b 3220 to 3772 2 to 554   capped   553/555
(99 %)
1 diff
(99.9 %id)
DB191196 lung, tumor tissue .b 3220 to 3789 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB289472 uterus .b 3226 to 3779 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
AW673285 cervix .b 3271 to 3507 10 to 247       238/276
(86 %)
23 diff
(91.7 %id)
T09303   .b 3320 to 3609 1 to 290       290/290
(100 %)
5 diff
(98.3 %id)
BG820889 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3328 to 3509 24 to 207       184/207
(88 %)
7 diff
(96.7 %id)
BG818177 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3366 to 3509 1 to 144       144/144
(100 %)
0 diff
(100 %id)
BQ718385 sympathetic trunk .b 3383 to 4158 1 to 784       784/922
(85 %)
19 diff
(98.0 %id)
BE838206 prostate_normal .b 3384 to 3786 1 to 402       402/404
(99 %)
6 diff
(98.6 %id)
BE838207 prostate_normal .b 3389 to 3786 7 to 403       397/405
(98 %)
11 diff
(97.3 %id)
BE838205 prostate_normal .b 3398 to 3786 1 to 389       389/391
(99 %)
6 diff
(98.5 %id)
DA218951 brain .b 3424 to 3895 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
CO248095 Chondrosarcoma Lung Metastasis cell lines, lung .b 3500 to 4195 8 to 698       691/809
(85 %)
7 diff
(99.2 %id)
BE840041 prostate_normal .b 3512 to 3888 14 to 390       377/390
(96 %)
6 diff
(98.5 %id)
BQ923788 epidermoid carcinoma, cell line, lung .b 3536 to 4447 24 to 942       919/942
(97 %)
26 diff
(97.3 %id)
BI022683 marrow .b 3608 to 3910 303 to 1       303/304
(99 %)
15 diff
(95.1 %id)
BG334747 melanotic melanoma, skin .b 3620 to 4347 1 to 721       721/726
(99 %)
30 diff
(95.9 %id)
BG477939 melanotic melanoma, skin .b 3620 to 4276 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
ES314015 occipital scalp hair, skin .b 3649 to 3830 1 to 180       180/180
(100 %)
3 diff
(98.4 %id)
F00204 leg muscle, skeletal muscle .b 3666 to 3870 1 to 205       205/206
(99 %)
2 diff
(99.1 %id)
Z24945 leg muscle, skeletal muscle .b 3667 to 3870 205 to 2       204/206
(99 %)
1 diff
(99.6 %id)
BM925150 pooled lung and spleen .b 3698 to 4622 1 to 936       934/1117
(83 %)
30 diff
(97.4 %id)
BI255263 cervical carcinoma cell line, cervix .b 3699 to 4395 1 to 693       693/694
(99 %)
6 diff
(99.2 %id)
BU168143 melanotic melanoma, cell line, skin .b 3716 to 4573 1 to 864       864/864
(100 %)
17 diff
(98.1 %id)
CN373196 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3748 to 4213 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
CR613640 Neuroblastoma Cot 10-normalized .b 3760 to 5545 1 to 1786       1786/1786
(100 %)
0 diff
(100 %id)
AL519820 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 3760 to 4853 1 to 1089       1089/1097
(99 %)
17 diff
(98.5 %id)
BX344799 Neuroblastoma Cot 10-normalized .b 3760 to 4528 1 to 763       763/763
(100 %)
8 diff
(99.0 %id)
BI160990 epithelioid carcinoma cell line, Pancreas .b 3801 to 4535 1 to 746       746/864
(86 %)
31 diff
(96.5 %id)
BM790197 stomach .b 3809 to 4275 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BM854589 stomach .b 3809 to 4248 1 to 440       440/440
(100 %)
3 diff
(99.4 %id)
BI457159 epithelioid carcinoma cell line, Pancreas .b 3816 to 4616 1 to 802       802/844
(95 %)
23 diff
(97.3 %id)
TI_45133399   .b 3817 to 4616 62 to 862       801/843
(95 %)
22 diff
(97.4 %id)
BI257676 cervical carcinoma cell line, cervix .b 3866 to 4671 1 to 811       811/812
(99 %)
27 diff
(96.7 %id)
AA351405 brain .b 3922 to 4150 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
BU159938 eye, retinoblastoma .b 3925 to 4614 1 to 690       690/914
(75 %)
4 diff
(99.6 %id)
AA132836 colon, tumor .b 3926 to 4123 1 to 201       201/204
(98 %)
6 diff
(97.1 %id)
TI_57177526   .b 3951 to 4780 25 to 852       828/852
(97 %)
13 diff
(98.5 %id)
BE838163 prostate_normal .b 3955 to 4203 255 to 9       247/262
(94 %)
0 diff
(100 %id)
BI766567 pooled lung and spleen .b 3957 to 4780 1 to 823       823/823
(100 %)
10 diff
(98.8 %id)
BE779344 eye, retinoblastoma .b 3966 to 4089 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
CK429514 eye, lacrimal gland .b 4026 to 4682 1 to 657       657/657
(100 %)
0 diff
(100 %id)
CN373203 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4130 to 4757 1 to 628       628/628
(100 %)
0 diff
(100 %id)
CU446047 epidermis .b 4158 to 4893 752 to 17     Submitted on the opposite strand 734/752
(97 %)
1 diff
(99.9 %id)
BQ549848 insulinoma, Pancreas .b 4162 to 4597 1 to 436     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 436/436
(100 %)
6 diff
(98.7 %id)
BF338586 brain, glioblastoma with EGFR amplification .b 4178 to 4892 9 to 727       719/868
(82 %)
11 diff
(98.8 %id)
CU451155 epidermis .b 4202 to 4893 708 to 17     Submitted on the opposite strand 690/708
(97 %)
1 diff
(99.9 %id)
BQ346205 nervous_tumor .b 4206 to 4395 12 to 196       185/196
(94 %)
6 diff
(97.0 %id)
BG327414 Kidney, renal cell adenocarcinoma .b 4207 to 4962 1 to 751       751/837
(89 %)
10 diff
(98.9 %id)
BM561990 leukocyte .b 4209 to 5035 11 to 838       828/1127
(73 %)
15 diff
(98.7 %id)
BM793654 Ascites, stomach .b 4230 to 4783 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
CF137092 lymph .b 4236 to 4484 8 to 256       249/256
(97 %)
6 diff
(97.7 %id)
TI_154166429   .b 4236 to 4538 78 to 381       304/539
(56 %)
3 diff
(99.5 %id)
AW247986 lung, small cell carcinoma .b 4241 to 4482 1 to 242       242/242
(100 %)
6 diff
(97.6 %id)
AW245565 lung, small cell carcinoma .b 4241 to 4312 1 to 72       72/72
(100 %)
4 diff
(94.5 %id)
AW887831 ovary .b 4264 to 4859 80 to 671       592/681
(86 %)
26 diff
(96.2 %id)
D17040   .b 4318 to 4656 1 to 340       338/340
(99 %)
6 diff
(98.3 %id)
EC475401 Prostate .b 4329 to 4442 111 to 1       111/118
(94 %)
4 diff
(96.7 %id)
EC476297 Prostate .b 4329 to 4442 115 to 1       115/122
(94 %)
2 diff
(98.4 %id)
EC491716 Prostate .b 4329 to 4442 114 to 1       114/121
(94 %)
1 diff
(99.2 %id)
EC519553 Prostate .b 4329 to 4441 114 to 3       112/121
(92 %)
0 diff
(100 %id)
EC534310 Prostate .b 4329 to 4442 112 to 1       112/119
(94 %)
3 diff
(97.5 %id)
BG898192 cartilage .b 4347 to 4692 78 to 423       346/355
(97 %)
5 diff
(98.6 %id)
BG900861 cartilage .b 4347 to 4913 26 to 591       566/591
(95 %)
9 diff
(98.5 %id)
BM546795 ovary (pool of 3) .b 4359 to 5305 1 to 951       951/1003
(94 %)
14 diff
(98.7 %id)
BF724869 eye, Iris .b 4360 to 4945 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BI012433 lung_normal .b 4431 to 4894 509 to 34       475/509
(93 %)
23 diff
(95.5 %id)
BE541545 cervix .b 4450 to 5119 1 to 675       675/852
(79 %)
17 diff
(98.1 %id)
BE545034 cervical carcinoma cell line, cervix .b 4461 to 5160 1 to 701       699/813
(85 %)
20 diff
(97.6 %id)
CA487665   .b 4461 to 5354 1 to 902       902/923
(97 %)
11 diff
(98.9 %id)
CN373206 embryonic stem cells, cell lines H1, H7, andH9 .b 4464 to 4928 1 to 465       465/465
(100 %)
2 diff
(99.6 %id)
H58839 liver and spleen .b 4473 to 4856 13 to 400       388/417
(93 %)
18 diff
(95.7 %id)
H91209 liver and spleen .b 4473 to 4655 1 to 183       183/185
(98 %)
3 diff
(98.4 %id)
BX112945 liver and spleen .b 4474 to 5144 1 to 670       670/670
(100 %)
2 diff
(99.8 %id)
CT004214 T-Lymphocytes .b 4491 to 5379 1 to 889       889/889
(100 %)
4 diff
(99.6 %id)
BE779711 eye, retinoblastoma .b 4500 to 5136 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
M78940   .b 4510 to 4894 1 to 385       385/385
(100 %)
4 diff
(99.0 %id)
BM708126 eye, RPE and Choroid .b 4522 to 4979 1 to 458   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
BI856165 breast, mammary adenocarcinoma, cell line .b 4528 to 5298 1 to 771       771/772
(99 %)
12 diff
(98.5 %id)
TI_57186024   .b 4528 to 5298 54 to 824       771/772
(99 %)
12 diff
(98.5 %id)
BE720470 head_neck .b 4532 to 4923 8 to 401       394/406
(97 %)
9 diff
(97.8 %id)
BE933648 head_neck .b 4532 to 4914 1 to 380       380/380
(100 %)
8 diff
(97.9 %id)
BE933881 head_neck .b 4532 to 4914 1 to 380       380/380
(100 %)
8 diff
(97.9 %id)
BE933591 head_neck .b 4536 to 4914 382 to 5       378/385
(98 %)
6 diff
(98.5 %id)
AL519819 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 4540 to 5545 1002 to 1       1002/1005
(99 %)
7 diff
(99.4 %id)
BE720464 head_neck .b 4564 to 4928 365 to 1       365/365
(100 %)
5 diff
(98.7 %id)
CB156969 Liver .b 4570 to 5031 24 to 485       462/485
(95 %)
6 diff
(98.8 %id)
CD579589 brain .b 4580 to 5169 1 to 592       592/593
(99 %)
3 diff
(99.5 %id)
BI029351 marrow .b 4583 to 4949 1 to 367       367/377
(97 %)
12 diff
(96.9 %id)
BE720368 head_neck .b 4586 to 4922 338 to 3       336/338
(99 %)
1 diff
(99.8 %id)
AW905866 nervous_normal .b 4616 to 5072 14 to 469       456/469
(97 %)
7 diff
(98.6 %id)
AA421025   .b 4616 to 5144 1 to 528       528/529
(99 %)
2 diff
(99.7 %id)
BE763705 nervous_tumor .b 4617 to 5053 1 to 437       437/446
(97 %)
2 diff
(99.6 %id)
BI022707 marrow .b 4624 to 4964 1 to 342       342/342
(100 %)
7 diff
(98.0 %id)
BG334170 melanotic melanoma, skin .b 4640 to 5301 1 to 653       653/993
(65 %)
14 diff
(98.6 %id)
BQ787406 insulinoma, Pancreas .b 4644 to 5203 8 to 567       560/581
(96 %)
19 diff
(96.8 %id)
BU073101 insulinoma, Pancreas .b 4644 to 5149 8 to 513   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 506/513
(98 %)
6 diff
(98.9 %id)
BI022633 marrow .b 4654 to 4998 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
BF982935 duodenal adenocarcinoma, cell line, small intestine .b 4662 to 5292 1 to 621   AAA   621/831
(74 %)
13 diff
(98.5 %id)
BM717180 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 4664 to 5065 1 to 402   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 402/402
(100 %)
0 diff
(100 %id)
AW372224 breast .b 4668 to 4914 28 to 274       247/274
(90 %)
7 diff
(97.5 %id)
S82474   .b 4685 to 4779 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
H18372 brain .b 4693 to 5070 1 to 379       379/420
(90 %)
6 diff
(98.6 %id)
BF526806 brain, glioblastoma with EGFR amplification .b 4695 to 5459 1 to 756       756/1008
(75 %)
21 diff
(98.0 %id)
BF928443 nervous_tumor .b 4700 to 5150 1 to 452       452/452
(100 %)
7 diff
(98.5 %id)
H51358 brain .b 4700 to 5116 1 to 419       419/469
(89 %)
17 diff
(96.4 %id)
BG911251 anaplastic oligodendroglioma with 1p/19qloss, brain .b 4700 to 5567 1 to 863       863/865
(99 %)
28 diff
(96.8 %id)
BQ231266 melanotic melanoma, skin .b 4701 to 5542 1 to 858       858/931
(92 %)
19 diff
(98.0 %id)
H20433 brain .b 4705 to 5112 26 to 438       413/451
(91 %)
16 diff
(96.5 %id)
TI_149303902   .b 4705 to 5563 947 to 99   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 849/930
(91 %)
18 diff
(98.1 %id)
AW378884 head_neck .b 4713 to 4949 12 to 248       237/262
(90 %)
8 diff
(97.0 %id)
BE843024 stomach .b 4728 to 5017 1 to 290       290/290
(100 %)
0 diff
(100 %id)
TI_149303883   .b 4736 to 5570 910 to 82   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 829/946
(87 %)
9 diff
(99.1 %id)
AW606089 head_neck .b 4739 to 4926 1 to 187       187/190
(98 %)
11 diff
(94.3 %id)
BM825735 Ascites, stomach .b 4754 to 5080 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
BF853682 lung_normal .b 4780 to 5008 1 to 229       229/229
(100 %)
2 diff
(99.2 %id)
BM981801 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 4784 to 5570 803 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 785/785
(100 %)
5 diff
(99.4 %id)
N73371 liver and spleen .b 4794 to 5102 1 to 310       310/312
(99 %)
3 diff
(99.1 %id)
TI_154134363   .b 4812 to 5563 842 to 90   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 753/755
(99 %)
33 diff
(95.7 %id)
EC475050 Prostate .b 4833 to 4918 9 to 94       86/94
(91 %)
6 diff
(93.7 %id)
AJ712349 bone marrow .b 4839 to 5367 1 to 529       529/529
(100 %)
0 diff
(100 %id)
AL048415 uterus .b 4842 to 5570 747 to 24   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 724/772
(93 %)
20 diff
(97.5 %id)
BG819039 anaplastic oligodendroglioma with 1p/19qloss, brain .b 4844 to 5541 1 to 697       697/697
(100 %)
4 diff
(99.5 %id)
DB572361 hypothalamus .b 4847 to 5570 1 to 724     Submitted on the opposite strand 724/724
(100 %)
7 diff
(99.1 %id)
CD368394 Alveolar Macrophage, lung .b 4848 to 5561 732 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 714/714
(100 %)
0 diff
(100 %id)
BG912163 anaplastic oligodendroglioma with 1p/19qloss, brain .b 4851 to 5563 13 to 725   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 713/725
(98 %)
9 diff
(98.8 %id)
TI_149288677   .b 4869 to 5570 781 to 80   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 702/703
(99 %)
1 diff
(99.9 %id)
BM981817 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 4874 to 5563 706 to 17   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 690/690
(100 %)
3 diff
(99.6 %id)
BQ721421 sympathetic trunk .b 4879 to 5553 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BF155002 breast .b 4885 to 5085 208 to 8       201/243
(82 %)
10 diff
(95.9 %id)
BM970502 lung .b 4889 to 5570 700 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
BU596115 mixed (pool of 40 RNAs) .b 4893 to 5271 380 to 1     Submitted on the opposite strand 380/916
(41 %)
4 diff
(99.6 %id)
AW027696 thymus, pooled .b 4895 to 5553 659 to 1       659/660
(99 %)
5 diff
(99.3 %id)
AA806139 epithelium (cell line), Prostate .b 4897 to 5540 639 to 1       639/642
(99 %)
13 diff
(98.0 %id)
EC478950 Prostate .b 4921 to 5024 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
BU731977 eye, RPE and Choroid .b 4949 to 5559 627 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 609/609
(100 %)
4 diff
(99.4 %id)
AI201171   .b 4966 to 5561 623 to 28   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 529/596
(88 %)
40 diff
(93.3 %id)
BE300943 Burkitt lymphoma, lymph .b 4966 to 5551 597 to 12   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 586/586
(100 %)
17 diff
(97.1 %id)
BE300641 Burkitt lymphoma, lymph .b 4999 to 5551 563 to 11   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 553/553
(100 %)
1 diff
(99.9 %id)
BU738647 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 5004 to 5563 578 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 560/560
(100 %)
0 diff
(100 %id)
BQ359850 head_normal .b 5012 to 5250 240 to 2       239/240
(99 %)
9 diff
(96.3 %id)
BQ359864 head_normal .b 5012 to 5250 247 to 9       239/247
(96 %)
8 diff
(96.8 %id)
FN061774 breast carcinoma .b 5027 to 5128 102 to 1     Submitted on the opposite strand 102/102
(100 %)
0 diff
(100 %id)
AU148752   .b 5027 to 5551 527 to 1       527/540
(97 %)
11 diff
(98.0 %id)
AW675638 cervix .b 5032 to 5570 539 to 1       539/539
(100 %)
0 diff
(100 %id)
EC526077 Prostate .b 5035 to 5138 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
BQ331780 lung_tumor .b 5037 to 5266 14 to 252       235/256
(91 %)
16 diff
(93.8 %id)
DB370673   .b 5065 to 5563 499 to 1       499/556
(89 %)
11 diff
(98.1 %id)
BQ613981 insulinoma, Pancreas .b 5111 to 5561 466 to 16   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 451/451
(100 %)
2 diff
(99.6 %id)
H20434 brain .b 5116 to 5563 452 to 1       452/482
(93 %)
12 diff
(97.6 %id)
BU071095 insulinoma, Pancreas .b 5119 to 5570 469 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
EC525779 Prostate .b 5123 to 5208 88 to 3       86/98
(87 %)
0 diff
(100 %id)
H50519 brain .b 5126 to 5520 397 to 1       397/398
(99 %)
11 diff
(97.3 %id)
AA132707 colon, tumor .b 5141 to 5570 433 to 1       433/433
(100 %)
11 diff
(97.5 %id)
AA469955   .b 5164 to 5564 403 to 4       400/405
(98 %)
13 diff
(96.8 %id)
EC573682 Prostate .b 5181 to 5279 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
AW673195 cervical carcinoma cell line, cervix .b 5193 to 5464 272 to 1       272/325
(83 %)
21 diff
(93.6 %id)
AW576510 lymph .b 5211 to 5563 368 to 16   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
H58787 liver and spleen .b 5297 to 5543 245 to 1       245/263
(93 %)
8 diff
(97.0 %id)
H91159 liver and spleen .b 5297 to 5520 225 to 1       225/247
(91 %)
5 diff
(98.0 %id)
AB210000   .c 1 to 5421 1 to 5421 exact tiling clone,   5421/5421
(100 %)
0 diff
(100 %id)
NM_001077183.1   .c 1 to 5430 1 to 5430 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 5430/5430
(100 %)
0 diff
(100 %id)
BF758873 colon .c 2662 to 3028 412 to 44     Submitted on the opposite strand 369/414
(89 %)
6 diff
(98.6 %id)
DA716975   .c 2668 to 3212 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA630331 Kidney .c 2760 to 3344 2 to 586   capped   585/590
(99 %)
2 diff
(99.7 %id)
BG818563 anaplastic oligodendroglioma with 1p/19qloss, brain .c 2799 to 3369 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
DA651869   .c 2829 to 3387 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
CN373193 embryonic stem cells, cell lines H1, H7, andH9 .c 2876 to 3399 13 to 536       524/536
(97 %)
6 diff
(98.9 %id)
DA737666   .c 2877 to 3715 2 to 834   capped   833/840
(99 %)
19 diff
(97.8 %id)
BM708268 eye, RPE and Choroid .c 2891 to 3410 10 to 529     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 520/530
(98 %)
7 diff
(98.7 %id)
BU731358 eye, RPE and Choroid .c 4830 to 5423 612 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 594/594
(100 %)
0 diff
(100 %id)
AK295728 hippocampus .d 1 to 5428 2 to 5429 E403V S433P L717P tiling clone,   5428/5429
(99 %)
3 diff
(100.0 %id)
DA325122 hippocampus .d 1 to 558 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AI871288 anaplastic oligodendroglioma, brain .d 4754 to 5414 670 to 11   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 660/661
(99 %)
23 diff
(96.6 %id)
AA595571 colon, tumor .d 4805 to 5394 587 to 1       587/587
(100 %)
17 diff
(97.2 %id)
AI954962 four pooled poorly-differentiatedadenocarcinomas, lung .d 4808 to 5425 625 to 8       618/625
(98 %)
8 diff
(98.8 %id)
AA928397 adenocarcinoma, colon .d 4811 to 5422 613 to 3       609/613
(99 %)
22 diff
(96.5 %id)
BU167214 melanotic melanoma, skin .d 4816 to 5417 1 to 602   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 602/602
(100 %)
1 diff
(99.9 %id)
AI005181 breast .d 4821 to 5416 592 to 1       592/596
(99 %)
5 diff
(99.2 %id)
BQ267158 insulinoma, Pancreas .d 4828 to 5324 8 to 504       497/504
(98 %)
7 diff
(98.7 %id)
BU069705 insulinoma, Pancreas .d 4828 to 5413 8 to 593       586/593
(98 %)
7 diff
(98.9 %id)
BU634083 cell lines, Chondrosarcoma .d 4830 to 5415 604 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 586/586
(100 %)
4 diff
(99.4 %id)
W88858 liver and spleen .d 4838 to 5090 1 to 250   fully sequenced,   250/250
(100 %)
2 diff
(99.2 %id)
BY799260 eye .d 4848 to 5429 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN373200 embryonic stem cells, cell lines H1, H7, andH9 .d 4852 to 5400 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
CA427637 Bone, Subchondral Bone .d 4853 to 5432 598 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 580/596
(97 %)
0 diff
(100 %id)
BF091950 testis_normal .d 4856 to 5183 335 to 8       328/335
(97 %)
4 diff
(98.9 %id)
AA788581   .d 4856 to 5417 601 to 42   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 558/560
(99 %)
33 diff
(94.2 %id)
AA610301 breast .d 4865 to 5419 567 to 17   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 551/551
(100 %)
10 diff
(98.2 %id)
CB269567 adipose .d 4866 to 5397 1 to 525       525/525
(100 %)
9 diff
(98.3 %id)
AI628693 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 4871 to 5415 586 to 42   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 545/547
(99 %)
9 diff
(98.4 %id)
AI799287 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 4881 to 5424 545 to 1       545/612
(89 %)
8 diff
(98.7 %id)
AI039971 senescent fibroblast .d 4887 to 5410 554 to 32   AAA   523/536
(97 %)
12 diff
(97.8 %id)
BQ018837 lung, Metastatic Chondrosarcoma .d 4887 to 5417 545 to 17   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 529/533
(99 %)
5 diff
(99.1 %id)
AA599437 bone marrow stroma .d 4888 to 5405 529 to 15   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 515/515
(100 %)
17 diff
(96.7 %id)
AI334126 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 4898 to 5417 518 to 1       518/518
(100 %)
5 diff
(99.1 %id)
AA564093 normal prostate, Prostate .d 4905 to 5415 523 to 16   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 508/509
(99 %)
8 diff
(98.5 %id)
AI025207   .d 4907 to 5425 524 to 6       519/524
(99 %)
8 diff
(98.5 %id)
BQ025541 placenta .d 4907 to 5407 516 to 17   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 500/501
(99 %)
6 diff
(98.9 %id)
R79494.
matches multiple genes
placenta .d 4915 to 5203 1 to 288     also hits gene TCEAL8 286/291
(98 %)
3 diff
(99.0 %id)
BI060178 uterus_tumor .d 4917 to 5412 496 to 1       496/496
(100 %)
0 diff
(100 %id)
BP392932 pancreatic islet .d 4917 to 5417 1 to 501     Submitted on the opposite strand 501/501
(100 %)
0 diff
(100 %id)
AI024801   .d 4926 to 5425 502 to 4       499/507
(98 %)
6 diff
(98.9 %id)
AI573134 adenocarcinoma, Pancreas .d 4926 to 5428 523 to 26   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 498/503
(99 %)
13 diff
(97.5 %id)
AI432688 lymph node, lymphoma, follicular mixed small and largecell .d 4928 to 5425 499 to 2       498/499
(99 %)
0 diff
(100 %id)
AA608516 lung, lung carcinoma .d 4949 to 5425 480 to 4       477/480
(99 %)
6 diff
(98.8 %id)
AW131049 Kidney, renal cell tumor .d 4957 to 5425 469 to 3       467/535
(87 %)
24 diff
(95.6 %id)
AA653136   .d 4967 to 5425 454 to 1       454/454
(100 %)
13 diff
(97.2 %id)
R69235 placenta .d 4968 to 5408 442 to 1       442/446
(99 %)
15 diff
(96.7 %id)
AI285274 adenocarcinoma, colon .d 4968 to 5424 457 to 1       457/482
(94 %)
7 diff
(98.6 %id)
AI088282 heart .d 4973 to 5417 438 to 1       438/438
(100 %)
15 diff
(96.6 %id)
BF438864 pooled .d 4973 to 5406 435 to 1       435/443
(98 %)
11 diff
(97.6 %id)
BF736718 bladder_tumor .d 4974 to 5259 295 to 5     Submitted on the opposite strand 291/296
(98 %)
14 diff
(95.3 %id)
AI078136   .d 4983 to 5418 440 to 5       436/440
(99 %)
1 diff
(99.8 %id)
TI_149274231   .d 5007 to 5419 541 to 129   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 413/939
(43 %)
4 diff
(99.6 %id)
BM968415 lung, Primary Lung Epithelial Cells .d 5007 to 5419 427 to 15   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 413/479
(86 %)
4 diff
(99.2 %id)
AA968962 Kidney, kidney tumor .d 5008 to 5405 396 to 1       396/396
(100 %)
6 diff
(98.5 %id)
H41750 brain .d 5022 to 5400 378 to 1       378/378
(100 %)
7 diff
(98.2 %id)
AW150772 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 5022 to 5424 403 to 1       403/464
(86 %)
10 diff
(97.9 %id)
ES313908 beard hair, skin .d 5023 to 5403 1 to 381       381/381
(100 %)
0 diff
(100 %id)
W88539 liver and spleen .d 5037 to 5424 389 to 1   fully sequenced,   389/389
(100 %)
7 diff
(98.3 %id)
AA299573 uterus .d 5055 to 5239 1 to 186       186/186
(100 %)
5 diff
(97.4 %id)
AI307587 early stage papillary serous carcinoma, ovary .d 5057 to 5242 1 to 186     Submitted on the opposite strand 186/186
(100 %)
3 diff
(98.4 %id)
AA858108 adenocarcinoma, colon .d 5065 to 5424 356 to 1       356/358
(99 %)
4 diff
(98.9 %id)
BM966762 Islets of Langerhans, Pancreas .d 5069 to 5424 12 to 367   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 356/367
(97 %)
6 diff
(98.4 %id)
CK823223 Islets of Langerhans, Pancreas .d 5069 to 5424 12 to 367   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 356/369
(96 %)
7 diff
(98.2 %id)
BM966853 Islets of Langerhans, Pancreas .d 5069 to 5424 12 to 367   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 356/367
(97 %)
6 diff
(98.4 %id)
BM996116 lung, Metastatic Chondrosarcoma .d 5071 to 5405 355 to 21   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 335/359
(93 %)
1 diff
(99.8 %id)
TI_57175947   .d 5079 to 5417 59 to 397       339/397
(85 %)
6 diff
(98.5 %id)
BI829593 brain, medulla .d 5081 to 5417 1 to 337       337/337
(100 %)
0 diff
(100 %id)
AI950188 pooled germ cell tumors .d 5086 to 5407 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AI962215 pooled germ cell tumors .d 5086 to 5407 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AI041012   .d 5087 to 5428 362 to 21   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 342/342
(100 %)
3 diff
(99.2 %id)
TI_227713399   .d 5088 to 5424 415 to 80   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 336/342
(98 %)
2 diff
(99.5 %id)
T28377 colon, epididymis .d 5092 to 5353 1 to 263       263/264
(99 %)
3 diff
(98.9 %id)
AW950530   .d 5093 to 5409 1 to 317   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
CA428833 Bone, Subchondral Bone .d 5093 to 5417 343 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 325/326
(99 %)
0 diff
(100 %id)
CD367702 Alveolar Macrophage, lung .d 5099 to 5424 344 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 326/326
(100 %)
0 diff
(100 %id)
AI796208 Kidney .d 5107 to 5425 320 to 4       317/320
(99 %)
0 diff
(100 %id)
AW050749 colon, colonic mucosa from 3 patients with Crohn'sdisease .d 5107 to 5425 325 to 6       320/325
(98 %)
6 diff
(98.2 %id)
BU947218 insulinoma, Pancreas .d 5110 to 5417 8 to 315       308/315
(97 %)
0 diff
(100 %id)
BU729896 eye, Retina Foveal and Macular .d 5115 to 5424 328 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 310/310
(100 %)
1 diff
(99.7 %id)
BF886491 testis_normal .d 5119 to 5343 223 to 1     Submitted on the opposite strand 223/223
(100 %)
2 diff
(99.2 %id)
H40217 brain .d 5130 to 5402 284 to 13       272/284
(95 %)
3 diff
(99.0 %id)
BF062599 colon, colon tumor, RER+ .d 5150 to 5417 270 to 3       268/270
(99 %)
0 diff
(100 %id)
AA776799   .d 5151 to 5407 256 to 1       256/262
(97 %)
4 diff
(98.5 %id)
C21176   .d 5159 to 5428 1 to 272       272/272
(100 %)
4 diff
(98.6 %id)
AI197938 Prostate .d 5159 to 5415 278 to 22   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 257/257
(100 %)
3 diff
(98.9 %id)
AI686382 Prostate .d 5159 to 5415 280 to 22   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 259/259
(100 %)
4 diff
(98.5 %id)
AI915046 ovary, tumor, 5 pooled (see description) .d 5168 to 5415 280 to 31   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 250/261
(95 %)
4 diff
(98.5 %id)
CF137874 lymph .d 5207 to 5406 240 to 41     Submitted on the opposite strand 200/240
(83 %)
0 diff
(100 %id)
BM987875 mixed .d 5216 to 5424 227 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
AW205939   .d 5234 to 5424 208 to 18   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 191/201
(95 %)
0 diff
(100 %id)
BP389931 pancreatic islet .d 5248 to 5422 1 to 176     Submitted on the opposite strand 176/182
(96 %)
2 diff
(99.0 %id)
CD105600 brain, Pituitary .d 5257 to 5410 1 to 154       154/184
(83 %)
3 diff
(98.4 %id)
AI199255 Prostate .d 5267 to 5425 162 to 4       159/162
(98 %)
0 diff
(100 %id)
AI972974 Prostate .d 5267 to 5424 158 to 1       158/158
(100 %)
0 diff
(100 %id)
EC573493 Prostate .d 5310 to 5414 104 to 3       102/104
(98 %)
0 diff
(100 %id)
T09245   .d 5416 to 5769 1 to 352       352/352
(100 %)
7 diff
(98.1 %id)
CN268814 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 5421 to 6050 44 to 679       636/679
(93 %)
8 diff
(98.9 %id)
CD675968 eye, lens .d 5421 to 6003 18 to 600       583/600
(97 %)
6 diff
(99.0 %id)
BP386005 pancreatic islet .d 5421 to 5896 476 to 1       476/478
(99 %)
2 diff
(99.6 %id)
DR977711 brain .d 5421 to 5497 82 to 7       76/90
(84 %)
0 diff
(100 %id)
AW504511 lymph .d 5421 to 5793 42 to 414       373/414
(90 %)
7 diff
(98.4 %id)
CF136053 lymph .d 5421 to 6080 40 to 698   tiling clone,   659/698
(94 %)
6 diff
(99.2 %id)
CF136468 lymph .d 5421 to 5731 42 to 354       313/354
(88 %)
6 diff
(98.4 %id)
CF136714 lymph .d 5421 to 5777 40 to 396       357/396
(90 %)
6 diff
(98.5 %id)
CV808922 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 5421 to 6161 32 to 771       740/900
(82 %)
6 diff
(99.4 %id)
TI_154160696   .d 5421 to 5964 120 to 664       545/580
(93 %)
22 diff
(96.3 %id)
TI_154164864   .d 5421 to 6174 110 to 851       742/898
(82 %)
13 diff
(98.6 %id)
TI_154165874   .d 5421 to 5854 112 to 547       436/471
(92 %)
16 diff
(96.7 %id)
AL041918 testis .d 5423 to 5804 63 to 444       382/444
(86 %)
6 diff
(98.7 %id)
DB526613.
matches multiple genes
testis .d 5423 to 5875 453 to 1     also hits gene PKD1 453/454
(99 %)
1 diff
(99.8 %id)
DB539375 hippocampus .d 5423 to 6084 662 to 1       662/662
(100 %)
1 diff
(99.9 %id)
DB552168.
matches multiple genes
hippocampus .d 5423 to 5892 470 to 1     also hits gene PKD1 470/470
(100 %)
0 diff
(100 %id)
DB567786.
matches multiple genes
hypothalamus .d 5423 to 5890 469 to 2     also hits gene PKD1 468/469
(99 %)
0 diff
(100 %id)
DB570820.
matches multiple genes
hypothalamus .d 5423 to 5888 468 to 1     also hits gene PKD1 468/468
(100 %)
3 diff
(99.4 %id)
H86307 eye, retina .d 5423 to 5775 1 to 354       354/354
(100 %)
58 diff
(83.7 %id)
H85802 eye, retina .d 5460 to 5799 1 to 342       342/342
(100 %)
17 diff
(95.1 %id)
BF837332 head_neck .d 5469 to 5756 1 to 288       288/288
(100 %)
4 diff
(98.7 %id)
BU949294 Pancreas, Purified pancreatic islet .d 5495 to 5794 1 to 300       300/300
(100 %)
6 diff
(98.0 %id)
BU949484 Pancreas, Purified pancreatic islet .d 5495 to 5898 1 to 404       404/404
(100 %)
6 diff
(98.6 %id)
BF853940 lung_normal .d 5782 to 6164 1 to 382       382/382
(100 %)
3 diff
(99.3 %id)
CF137981 lymph .d 5793 to 6402 1 to 611   tiling clone,   611/611
(100 %)
9 diff
(98.6 %id)
TI_154167739   .d 5800 to 6455 80 to 739   tiling clone,   660/837
(78 %)
10 diff
(98.9 %id)
BI016353 lung_tumor .d 5828 to 6267 28 to 460       433/461
(93 %)
6 diff
(98.7 %id)
AA324657 brain, cerebellum .d 6081 to 6320 1 to 240       240/240
(100 %)
2 diff
(99.2 %id)
AV661660 corresponding non cancerous liver tissue .d 6118 to 6516 400 to 1   tiling clone,   400/400
(100 %)
29 diff
(92.8 %id)
AK299343   .e 1 to 5287 1 to 5287 N150S S298P S623N E925K E1159V ... tiling clone,   5287/5287
(100 %)
7 diff
(99.9 %id)
DC372612   .e 1 to 520 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
DA326606 hippocampus .f 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
DA834584 placenta .f 18 to 575 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
AK295672 hippocampus .f 28 to 5263 1 to 5236 exact tiling clone,   5236/5236
(100 %)
1 diff
(100.0 %id)
DA318404 hippocampus .f 29 to 578 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB079591 testis .f 2296 to 2861 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
BU176147 eye, retinoblastoma .f 2316 to 3191 1 to 891       889/922
(96 %)
16 diff
(98.3 %id)
CB145030 Liver .f 2377 to 2845 1 to 469       469/469
(100 %)
2 diff
(99.6 %id)
DA116183 cerebellum .f 2379 to 2962 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA679352   .f 2406 to 2974 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BU428800 lymph .f 2574 to 2965 8 to 399       392/399
(98 %)
0 diff
(100 %id)
TI_154149632   .f 2574 to 3094 81 to 601       521/521
(100 %)
3 diff
(99.5 %id)
BQ939637 large cell carcinoma, lung .f 2604 to 3400 1 to 798       798/954
(83 %)
9 diff
(99.1 %id)
BG760422 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3586 1 to 935       935/969
(96 %)
23 diff
(97.7 %id)
BG760791 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3429 1 to 787       787/1034
(76 %)
9 diff
(99.2 %id)
BG760709 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3432 1 to 785       785/926
(84 %)
7 diff
(99.3 %id)
BG761995 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3492 1 to 847       847/847
(100 %)
8 diff
(99.1 %id)
BG763844 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3497 1 to 855       855/856
(99 %)
28 diff
(96.8 %id)
BG764523 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3527 1 to 877       877/884
(99 %)
23 diff
(97.4 %id)
BG765842 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3471 1 to 820       820/820
(100 %)
12 diff
(98.6 %id)
BG767330 melanotic melanoma, high MDR (cell line), skin .f 2645 to 3382 1 to 740       740/741
(99 %)
8 diff
(99.0 %id)
BG766606 melanotic melanoma, high MDR (cell line), skin .f 2646 to 3429 2 to 807       806/925
(87 %)
62 diff
(93.3 %id)
TI_154157695   .f 2720 to 3296 665 to 89     Submitted on the opposite strand 577/583
(98 %)
1 diff
(99.9 %id)
BQ933738 large cell carcinoma, lung .f 2764 to 3693 1 to 934   tiling clone,   934/950
(98 %)
17 diff
(98.3 %id)
CF780855 Pooled Chondrosarcoma Tumor cells .f 2768 to 3427 8 to 669       662/976
(67 %)
10 diff
(99.0 %id)
DA850071 placenta .f 2770 to 3311 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
AW502379 lymph .f 2782 to 3296 528 to 14     Submitted on the opposite strand 515/528
(97 %)
0 diff
(100 %id)
BX647816 endometrium .g 1 to 5073 1 to 5073 T727A S750P tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 5073/5073
(100 %)
5 diff
(100.0 %id)
DA446043 tongue, tumor tissue .h 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
BX404907 placenta .h 140 to 968 1 to 823   tiling clone,   823/865
(95 %)
12 diff
(98.7 %id)
BX404906 placenta .h 2325 to 3185 865 to 1   tiling clone,   865/865
(100 %)
19 diff
(97.9 %id)
DB313973 tongue, tumor tissue .h 2730 to 3282 553 to 1   tiling clone,   553/553
(100 %)
0 diff
(100 %id)
AL703785 human skeletal muscle .i 1 to 600 1 to 601   tiling clone,   601/601
(100 %)
2 diff
(99.7 %id)
DB134307 thymus .i 269 to 808 2 to 541   capped   540/541
(99 %)
1 diff
(99.9 %id)
CN413689 embryonic stem cells, cell lines H1, H7, andH9 .i 326 to 855 1 to 530   tiling clone,   530/530
(100 %)
0 diff
(100 %id)
DA101457 cerebellum .i 370 to 957 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB066997 testis .i 659 to 1126 2 to 473   capped   472/472
(100 %)
4 diff
(99.2 %id)
DA105645 cerebellum .i 757 to 1298 2 to 544   tiling clone, capped   543/547
(99 %)
3 diff
(99.5 %id)
BF340765 brain, glioblastoma with EGFR amplification .i 766 to 1451 1 to 692       692/977
(70 %)
35 diff
(96.5 %id)
DB276360 uterus .i 886 to 1369 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
BQ183628 Knee, Osteoarthritic Cartilage .i 928 to 1595 6 to 672     Submitted on the opposite strand 667/672
(99 %)
6 diff
(99.2 %id)
AW151619 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i 936 to 1342 17 to 423   AAA Submitted on the opposite strand 407/423
(96 %)
10 diff
(97.7 %id)
AW088312 ovary, tumor, 5 pooled (see description) .i 967 to 1411 475 to 30       446/475
(93 %)
0 diff
(100 %id)
DA232587 brain .i 989 to 1557 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AK125096 tongue, tumor tissue .i 1091 to 4338 1 to 3248 R16G L114P tiling clone, available from FLJ,   3248/3248
(100 %)
5 diff
(99.9 %id)
DB227197 trachea .i 1092 to 1672 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
CN412235 embryonic stem cells, cell lines H1, H7, andH9 .i 1259 to 1913 1 to 655       655/655
(100 %)
1 diff
(99.9 %id)
DA106412 cerebellum .i 1323 to 1785 2 to 466   capped   465/465
(100 %)
14 diff
(97.0 %id)
DA585243 lung .i 1330 to 1876 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA095391 cerebellum .i 1347 to 1873 2 to 530   capped   529/531
(99 %)
5 diff
(99.1 %id)
DA947715 Spleen .i 1405 to 1963 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DB117725 thymus .i 1597 to 2159 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA452830 tongue, tumor tissue .i 1769 to 2325 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DB124677 thymus .i 1770 to 2323 2 to 555   capped   554/554
(100 %)
4 diff
(99.3 %id)
DB121542 thymus .i 1771 to 2320 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA450334 tongue, tumor tissue .i 1772 to 2329 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA456846 tongue, tumor tissue .i 1773 to 2322 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB105040 thymus .i 1773 to 2323 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB109823 thymus .i 1773 to 2343 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB112910 thymus .i 1773 to 2347 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB115399 thymus .i 1773 to 2313 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB116580 thymus .i 1773 to 2289 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DB122726 thymus .i 1773 to 2305 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB126048 thymus .i 1773 to 2322 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB138595 thymus .i 1773 to 2319 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB139567 thymus .i 1773 to 2316 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB145687 thymus .i 1773 to 2273 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA445616 tongue, tumor tissue .i 1800 to 2380 2 to 582   tiling clone, capped   581/581
(100 %)
0 diff
(100 %id)
DA446289 tongue, tumor tissue .i 1800 to 2351 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB151388 thymus .i 1800 to 2364 2 to 566   capped   565/566
(99 %)
1 diff
(99.9 %id)
DB154505 thymus .i 1800 to 2383 2 to 585   capped   584/585
(99 %)
2 diff
(99.7 %id)
DB111929 thymus .i 1873 to 2445 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB342804 thymus .i 3823 to 4319 497 to 1       497/497
(100 %)
5 diff
(99.0 %id)
DA094388 cerebellum .j 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
0 diff
(100 %id)
DA092089 cerebellum .j 28 to 546 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA110937 cerebellum .j 28 to 606 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB158930 thymus .j 263 to 814 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA792820 brain .j 376 to 856 2 to 482   capped   481/481
(100 %)
1 diff
(99.8 %id)
DA103449 cerebellum .j 417 to 960 2 to 545   tiling clone, capped   544/544
(100 %)
1 diff
(99.9 %id)
DA990306 synovial membrane tissue from rheumatioidarthritis .j 543 to 1110 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA793916 brain .j 572 to 1119 2 to 549   tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
CT002126 T-Lymphocytes .j 619 to 1151 1 to 539       539/542
(99 %)
10 diff
(98.2 %id)
AK094152   .j 1067 to 3687 1 to 2621 exact tiling clone, available from FLJ,   2621/2621
(100 %)
2 diff
(100.0 %id)
DA027375   .j 1068 to 1643 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX508982   .j 1312 to 1971 1 to 663   tiling clone,   663/663
(100 %)
3 diff
(99.6 %id)
BG911713 anaplastic oligodendroglioma with 1p/19qloss, brain .j 1549 to 2063 1 to 537       537/903
(59 %)
32 diff
(96.5 %id)
DB110658 thymus .j 1695 to 2268 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BG696579 skin .j 1718 to 2522 1 to 821       821/887
(92 %)
37 diff
(95.9 %id)
BG696727 skin .j 1718 to 2434 1 to 741       741/742
(99 %)
32 diff
(95.7 %id)
TI_57244125   .j 1773 to 2531 55 to 824       770/824
(93 %)
31 diff
(96.3 %id)
BI914786 brain .j 1790 to 2531 1 to 755       755/755
(100 %)
32 diff
(95.8 %id)
DB117530 thymus .j 1814 to 2371 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB295712   .j 3152 to 3687 536 to 1       536/536
(100 %)
0 diff
(100 %id)
DB343297 thymus .j 3187 to 3699 513 to 1   tiling clone,   513/513
(100 %)
2 diff
(99.7 %id)
DA541228 lung .k 1 to 548 2 to 550   tiling clone, capped   549/549
(100 %)
5 diff
(99.1 %id)
CR601803 Placenta Cot 25-normalized .k 31 to 1686 1 to 1656 exact tiling clone,   1656/1656
(100 %)
0 diff
(100 %id)
BX396338 Placenta Cot 25-normalized .k 31 to 874 1 to 844   fully sequenced,   844/844
(100 %)
1 diff
(99.9 %id)
BX344977 Placenta Cot 25-normalized .k 31 to 898 1 to 872       872/872
(100 %)
21 diff
(97.6 %id)
BI769031 pooled lung and spleen .k 46 to 887 1 to 845       845/845
(100 %)
13 diff
(98.5 %id)
TI_57181855   .k 46 to 887 39 to 883       845/883
(95 %)
19 diff
(97.9 %id)
BX396337 Placenta Cot 25-normalized .k 813 to 1686 881 to 1   fully sequenced,   881/881
(100 %)
17 diff
(98.1 %id)
DA436442 tongue, tumor tissue .l 1 to 580 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DA786572 brain .l 12 to 604 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA921185 small intestine .l 328 to 910 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
DB059917 testis .l 328 to 875 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BI005393 head_normal .m 1 to 271 277 to -2   tiling clone,   276/277
(99 %)
0 diff
(100 %id)
DB099397 testis .m 1 to 589 2 to 590   tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
BI003985 head_normal .m 84 to 246 163 to 1       267/269
(99 %)
15 diff
(94.5 %id)
BM923098 leukocyte .m 411 to 1314 919 to 15   tiling clone, Submitted on the opposite strand 905/1065
(84 %)
15 diff
(98.6 %id)
DC350771 brain .n 1 to 543 1 to 543   tiling clone,   543/543
(100 %)
0 diff
(100 %id)
CN373202 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 5 to 712 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
AK294548 amygdala .n 13 to 1076 1 to 1064   tiling clone,   1064/1064
(100 %)
0 diff
(100 %id)
DC318473 amygdala .n 13 to 555 1 to 543       543/543
(100 %)
0 diff
(100 %id)
DC340016 thalamus .n 30 to 598 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC406310 thymus .n 30 to 593 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DC409860 thymus .n 30 to 630 1 to 601       601/601
(100 %)
0 diff
(100 %id)
DC320386 brain .n 36 to 599 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
DC418362 trachea .n 40 to 624 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
AW295919   .n 485 to 702 1 to 218     Submitted on the opposite strand 218/218
(100 %)
1 diff
(99.6 %id)
BF928832 nervous_tumor .n 604 to 1001 1 to 397       397/398
(99 %)
6 diff
(98.5 %id)
BG431241 Kidney .o 1 to 698 1 to 700   tiling clone,   700/700
(100 %)
9 diff
(98.8 %id)
BF833900 head_neck .o 230 to 439 10 to 221   tiling clone,   212/228
(92 %)
9 diff
(96.1 %id)
BQ434112 melanotic melanoma, skin .o 588 to 1438 1 to 872   tiling clone,   872/903
(96 %)
29 diff
(96.8 %id)
AW005974 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .o 1005 to 1414 410 to 1   tiling clone,   410/410
(100 %)
0 diff
(100 %id)
DA102014 cerebellum .p 1 to 482 74 to 555 exact tiling clone, capped   482/554
(87 %)
6 diff
(99.0 %id)
DA999722 breast, tumor tissue .q 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
4 diff
(99.3 %id)
BQ637574 eye, retina .q 102 to 554 1 to 453   tiling clone,   453/453
(100 %)
1 diff
(99.8 %id)
H52479 pineal gland .r 1 to 286 19 to 314   tiling clone, fully sequenced, Submitted on the opposite strand 296/314
(94 %)
8 diff
(97.5 %id)
H52478 pineal gland .r 225 to 457 310 to 73   tiling clone, fully sequenced, Submitted on the opposite strand 238/310
(76 %)
0 diff
(100 %id)
DB191372 lung, tumor tissue .s 1 to 574 2 to 575 G55V tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
CN373198 embryonic stem cells, cell lines H1, H7, andH9 .t 1 to 424 1 to 424 S14Y tiling clone,   424/424
(100 %)
3 diff
(99.3 %id)
BE939516 uterus .u 1 to 383 389 to 6   tiling clone,   384/389
(98 %)
0 diff
(100 %id)
BE892745 melanotic melanoma, skin .u 6 to 394 1 to 389   tiling clone,   389/389
(100 %)
0 diff
(100 %id)
AI335631 pooled germ cell tumors .u 8 to 462 453 to 1   tiling clone,   453/453
(100 %)
4 diff
(99.2 %id)
BQ710986 Spleen .va-u 1 to 666 1 to 666 exact tiling clone,   666/968
(68 %)
5 diff
(99.5 %id)
BQ708865 Spleen .va-u 1 to 805 1 to 815 exact tiling clone,   815/960
(84 %)
19 diff
(98.1 %id)
BF854058 lung_normal .va-u 172 to 672 518 to 17   tiling clone, Submitted on the opposite strand 502/518
(96 %)
0 diff
(100 %id)
BF904915 marrow .va-u 658 to 978 1 to 320   tiling clone,   320/320
(100 %)
3 diff
(99.1 %id)
BF058510 fibrotheoma, ovary .vb-u 1 to 571 571 to 1 exact tiling clone,   571/574
(99 %)
2 diff
(99.7 %id)
DA931640 Spleen .vc 1 to 478 2 to 479 exact tiling clone, capped   478/478
(100 %)
1 diff
(99.8 %id)
BQ368119 placenta_normal .vd 1 to 474 477 to 1   tiling clone,   477/485
(98 %)
18 diff
(96.3 %id)
BG911918 anaplastic oligodendroglioma with 1p/19qloss, brain .vd 16 to 606 1 to 615 L14S T15D T16H V17G E18G ... tiling clone,   573/873
(65 %)
24 diff
(97.3 %id)
DA107252 cerebellum .ve 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
DC409914 thymus .vf 1 to 335 1 to 334   tiling clone,   334/334
(100 %)
2 diff
(99.5 %id)
BE674952 B-cell, chronic lymphotic leukemia .vg 1 to 636 636 to 1 Y18T P19L S20P R27G E29X tiling clone,   636/636
(100 %)
3 diff
(99.6 %id)
DB124225 thymus .vh 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
AL120653 amygdala .vi 1 to 589 1 to 592 D59* tiling clone,   592/592
(100 %)
8 diff
(98.7 %id)
AK022401 mammary gland .vj-u 1 to 1800 2 to 1801   tiling clone, available from FLJ,   1801/1801
(100 %)
2 diff
(99.9 %id)
AU122370 mammary gland .vj-u 1 to 657 2 to 660   capped   659/662
(99 %)
7 diff
(99.0 %id)
BF756419 colon .vj-u 1073 to 1259 189 to 5     Submitted on the opposite strand 185/189
(97 %)
0 diff
(100 %id)
AU147962 mammary gland .vj-u 1246 to 1800 554 to 1       554/555
(99 %)
14 diff
(97.5 %id)
BF116008 fibrotheoma, ovary .vk-u 1 to 594 594 to 1 exact tiling clone,   594/594
(100 %)
3 diff
(99.5 %id)
DA016862 adrenal gland .vl 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
4 diff
(99.3 %id)
DA015334 adrenal gland .vl 12 to 580 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA010651 adrenal gland .vm 1 to 562 2 to 564 A76C C77M E78* tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DA807089 brain .vn 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
CN373195 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vo 1 to 542 1 to 542 exact tiling clone,   542/542
(100 %)
1 diff
(99.9 %id)
AA323670 brain, cerebellum .vp-u 1 to 277 1 to 277 P44X A51X S55M D56M A57P ... tiling clone,   277/277
(100 %)
3 diff
(99.0 %id)
DB328129 placenta Gene TSC2, variant not shown         This clone was ignored    
DB129852 thymus Gene TSC2, variant not shown       capped Suspected internal deletion, this clone was ignored    
BE720515 head_neck Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
DB272837 uterus Gene TSC2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB372144 ovary, tumor tissue Gene TSC2, variant not shown         This clone was ignored    
AU134449 ovary, tumor tissue Gene TSC2, variant not shown       capped This clone was ignored    
AA133645 colon, tumor Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
AA133752 colon, tumor Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
AA470834 colon Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
AA838749 parathyroid gland, parathyroid tumor Gene TSC2, variant not shown       AAA This clone was ignored    
AI371758 pooled germ cell tumors Gene TSC2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI337258 colon, colon tumor, RER+ Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
AW005110 anaplastic oligodendroglioma, brain Gene TSC2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BF514217   Gene TSC2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BU931496 ovary, teratocarcinoma, cell line Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
CD656945 Embryonic Stem cells Gene TSC2, variant not shown         Suspected internal deletion, this clone was ignored    
DA937291 Spleen Gene TSC2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB144810 thymus Gene TSC2, variant not shown       capped This clone was ignored    
DB345655 thymus Gene TSC2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb-u, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj-u, .vk-u, .vl, .vm, .vn, .vo, .vp-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI